You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 207 No. 12, March 24, 1969 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Subacute Sclerosing Panencephalitis

A Multidisciplinary Study of Eight Cases

J. T. Jabbour, MD; Julio H. Garcia, MD; Helio Lemmi, MD; James Ragland, PhD; Danilo A. Duenas, MD; John L. Sever, MD, PhD

JAMA. 1969;207(12):2248-2254.


Abstract

Clinical, electroencephalographic, and other laboratory features and subacute sclerosing panencephalitis (SSPE) were studied in eight patients by the same group of investigators. The relatively high frequency of the disease within a small geographical area in a short period of time suggests that SSPE may be unusually common in the vicinity of Memphis. The delineation of four clinical stages of the disease, markedly elevated measles antibody titers in serum and cerebrospinal fluid, ultrastructural observation of intranuclear and intracytoplasmic inclusions in neurons and neuroglia in three patients, and alteration of serum and CSF immunoglobulins indicate that the measles myxovirus may be the etiological agent in these patients.



Author Affiliations

From the departments of neurology (Dr. Lemmi) and biochemistry (Dr. Ragland), the Section of Pediatric Neurology (Drs. Jabbour and Duenas), and the Division of Neuropathology (Dr. Garcia), University of Tennessee Medical Units, Memphis; and the Section on Infectious Disease, Perinatal Research Branch, National Institute of Neurological Diseases and Blindness, Bethesda, Md (Dr. Sever).


Footnotes

Reprint requests to 848 Adams, Memphis 38103 (Dr. Jabbour).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Reduced Gray Matter Volume in the Frontotemporal Cortex of Patients with Early Subacute Sclerosing Panencephalitis
Aydin et al.
Am. J. Neuroradiol. 2009;30:271-275.
ABSTRACT | FULL TEXT  

Quantification of neurometabolites in subacute sclerosing panencephalitis by 1H-MRS.
Aydin et al.
Neurology 2006;67:911-913.
ABSTRACT | FULL TEXT  

Assessment of White Matter Damage in Subacute Sclerosing Panencephalitis Using Quantitative Diffusion Tensor MR Imaging.
Trivedi et al.
Am. J. Neuroradiol. 2006;27:1712-1716.
ABSTRACT | FULL TEXT  

Proton Magnetic Resonance Spectroscopy in a Case of Subacute Sclerosing Panencephalitis
Kato et al.
J Child Neurol 2002;17:788-790.
ABSTRACT  

Treatment of Subacute Sclerosing Panencephalitis With Interferon-{alpha}, Ribavirin, and Inosiplex
Solomon et al.
J Child Neurol 2002;17:703-705.
ABSTRACT  

Contribution of the Interleukin 4 Gene to Susceptibility to Subacute Sclerosing Panencephalitis
Inoue et al.
Arch Neurol 2002;59:822-827.
ABSTRACT | FULL TEXT  

Subacute Sclerosing Panencephalitis: Clinical and Magnetic Resonance Imaging Evaluation of 36 Patients
Ozturk et al.
J Child Neurol 2002;17:25-29.
ABSTRACT  

The Value of Serial Auditory Brainstem Response in Patients With Subacute Sclerosing Panencephalitis
Inagaki et al.
J Child Neurol 1999;14:422-427.
ABSTRACT  

Positron Emission Tomography Demonstrated Localized Luxury Perfusion in Subacute Sclerosing Panencephalitis
Yoshikawa et al.
J Child Neurol 1990;5:311-315.
ABSTRACT  

Intraventricular Interferon Treatment for Subacute Sclerosing Panencephalitis
Steiner et al.
J Child Neurol 1989;4:20-24.
ABSTRACT  

Cerebral Glucose Metabolism in the Course of Subacute Sclerosing Panencephalitis
Huber et al.
Arch Neurol 1989;46:97-100.
ABSTRACT  

CSF Antibody to Myelin Basic Protein: Measurement in Patients With Multiple Sclerosis and Subacute Sclerosing Panencephalitis
Panitch et al.
Arch Neurol 1980;37:206-209.
ABSTRACT  

The Variable Natural History of Subacute Sclerosing Panencephalitis: A Study of 118 Cases From the Middle East
Risk and Haddad
Arch Neurol 1979;36:610-614.
ABSTRACT  

Inosiplex in the Treatment of Subacute Sclerosing Panencephalitis
Silverberg et al.
Arch Neurol 1979;36:374-375.
ABSTRACT  

Substantial Spontaneous Long-term Improvement in Subacute Sclerosing Panencephalitis: Six Cases From the Middle East and a Review of the Literature
Risk et al.
Arch Neurol 1978;35:494-502.
ABSTRACT  

Subacute sclerosing panencephalitis: experimental infection in primates
Albrecht et al.
Science 1977;195:64-66.
ABSTRACT  

Ocular Manifestations of Subacute Sclerosing Panencephalitis
Morgan et al.
Arch Pediatr Adolesc Med 1976;130:1019-1021.
ABSTRACT  

Adult Onset of Subacute Sclerosing Panencephalitis
Cape et al.
Arch Neurol 1973;28:124-127.
ABSTRACT  

Maculopathy in Subacute Sclerosing Panencephalitis
Andriola and Karlsberg
Arch Pediatr Adolesc Med 1972;124:187-189.
ABSTRACT  

Subacute Encephalitis and Hypogammaglobulinemia
Hanissian et al.
Arch Pediatr Adolesc Med 1972;123:151-155.
ABSTRACT  

Ophthalmic Manifestations of Subacute Sclerosing Panencephalitis
Robb and Watters
Arch Ophthalmol 1970;83:426-435.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1969 American Medical Association. All Rights Reserved.